CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Dapagliflozin for treating chronic heart failure with reduced ejection fraction Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors

Editorial2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL:Can J Cardiol. Article Link

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett. Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF